Aeropowder, currently operating in Europe, has brought its deep-frozen and refrigerated PluumoPlus thermal packaging solutions to the US, as well as the new PluumoPlus 2-8°C Insulated Mailer for speciality pharmacies. The launch responds to fast-growing US demand for temperature-controlled healthcare logistics, where specialty medicines account for more than half of medicine spending, according to the IQVIA Institute.
PluumoPlus provides thermal performance up to 30% better than natural alternatives, the company says, competing with high-end polyurethane foam. The PluumoPlus Mailer puts this performance to work: the company has qualified it to maintain 2-8°C for 53 hours in a summer configuration and for 96 hours in a winter configuration against modified ISTA 7E profiles, offering up to 45% freight savings through smaller packages or a move from air to ground.
PluumoPlus products are already supplied in Europe to customers including GLP-1 distributors and clinical logistics companies.
Dr. Ryan Robinson, CEO and Founder of Aeropowder, said: “The healthcare supply chain needs solutions that perform better and are more sustainable, and that’s exactly what PluumoPlus delivers. We are keen to work with life science companies, logistics providers and packaging companies in the US who need high performance without compromising on sustainability.”
Aeropowder intends to scale PluumoPlus to millions of units annually in the US, establishing it as the new standard for premium thermal performance without single-use plastic foams.
Comments are closed.